CALSCREEN
Mark Identification

CALSCREEN

Serial Number

79109154

Filing Date

Dec 8, 2011

Registration Date

Jun 4, 2013

Trademark by

IMMUNDIAGNOSTIK AG

Classification Information

Chemicals, namely, monoclonal antibodies, buffers, and reagents for determination of calprotectin in disease testing for use in laboratory analysis; [ and reagents for in-vitro use in biochemistry, clinical chemistry and micro biology, for use in laboratory analysis; ] diagnostic preparations other than for medical and veterinary purposes, namely, diagnostic preparations for clinical or medical laboratory use in the nature of diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for determination of calprotectin for use in detecting diseases; [ diagnostic reagents for in-vitro use in biochemistry, clinical chemistry and micro biology, for use in detecting diseases; and ] diagnostic preparations for clinical or medical laboratory use in the nature of diagnostic kits for detecting, differentiating and monitoring chronic inflammatory diseases, infectious diseases, polyps, colon cancer, and intestinal and kidney disease [ diagnostic preparations other than for medical and veterinary purposes, namely, immunochromatographic test kits and chemical preparations consisting of pre-mixed reactants and reagents for the detection of calprotectin in stool, urine and other excreted body fluids for use in laboratory analysis; chemicals, namely, antibodies for use in industry, specifically in the manufacture of pharmaceuticals and chemical compositions for the preservation and extraction of proteineous analytes from stool for laboratory use ]

Chemicals

[ Biological preparations for medical and pharmaceutical purposes for the treatment of chronic inflammatory diseases, infectious diseases, polyps, colon cancer, intestinal diseases, and kidney disease; chemical substances, enzymes and antibodies for medical and pharmaceutical purposes for the treatment of chronic inflammatory diseases, infectious diseases, polyps, colon cancer, intestinal diseases, and kidney disease ]

Pharmaceuticals